Jennifer Litton
VP, Clinical Research, Clinical Research · University of Texas M D Anderson Cancer Center
Credentials: · · ·
History
Research
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
New England Journal of Medicine · 2018 · First of 18 authors · 1,704 citations
PD-L1 expression in triple-negative breast cancer
Cancer Immunology Research · 2014 · 1,143 citations
Journal of the National Comprehensive Cancer Network · 2021 · 914 citations
66 papers
Gabriel Hortobagyi
54 papers
54 papers
44 papers
35 papers
- SM
34 papers
33 papers
31 papers · 2 as a fellow
Grants
- 1996–2031
The University of Texas MD Anderson Cancer Center Support Grant (CCSG)
National Cancer Institute · P30
Project lead · $6.1M · University of Tx Md Anderson Can Ctr
Clinical trials
- 2017–2024
Principal investigator · Completed · Early phase 1
M.D. Anderson Cancer Center
- 2015–2022
Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
- 2009–2016
Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)
Principal investigator · Completed
M.D. Anderson Cancer Center
- 2001–2020
Primary Breast Cancer Occurring Concomitant With Pregnancy
Principal investigator · Completed · Early phase 1
M.D. Anderson Cancer Center